Department of Orthopedic Surgery, Indiana University School of Medicine, Indianapolis, IN.
J Orthop Trauma. 2018 Jul;32(7):327-332. doi: 10.1097/BOT.0000000000001167.
To determine the differences in costs and complications in patients with bicondylar tibial plateau (BTP) fractures treated with 1-stage definitive fixation compared with 2-stage fixation after initial spanning external fixation.
Retrospective cohort study.
Level 1 Trauma Center.
PATIENTS/PARTICIPANTS: Patients with OTA/AO 41-C (Schatzker 6) BTP fractures treated with open reduction internal fixation.
Definitive treatment with open reduction internal fixation either acutely (1 stage) or delayed after initial spanning external fixation (2 stage).
Wound healing complications, implant costs, hospital charges, Patient-Reported Outcomes Measurement Information System (PROMIS), reoperation, nonunion and infection.
One hundred five patients were identified over a three-year period, of whom 52 met the inclusion criteria. There were 28 patients in the 1-stage group and 24 patients in the 2-stage group. Mean follow-up was 21.8 months, and 87% of patients had at least 12 months of follow-up. The mean number of days to definitive fixation was 1.2 in the 1-stage group and 7.8 in the 2-stage group. There were no differences between groups with respect to wound healing or any other surgery-related complications. Functional outcomes PROMIS were similar between groups. Mean implant cost in the 2-stage group was $10,821 greater than the 1-stage group, mostly because of the costs of external fixation. Median hospital inpatient charges in the 2-stage group exceeded the 1-stage group by more than $68,000 for all BTP fractures and by $61,000 for isolated BTP fractures.
Early single-stage treatment of BTP fractures is cost-effective and is not associated with a higher complication rate than 2-stage treatment in appropriately selected patients.
Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
比较一期确定性固定与初始跨距外固定后二期固定治疗双髁胫骨平台(BTP)骨折患者的成本和并发症差异。
回顾性队列研究。
1 级创伤中心。
患者/参与者:接受切开复位内固定治疗的 OTA/AO 41-C(Schatzker 6)BTP 骨折患者。
急性(1 期)或初始跨距外固定后延迟(2 期)确定性治疗行切开复位内固定。
伤口愈合并发症、植入物成本、住院费用、患者报告结局测量信息系统(PROMIS)、再次手术、骨不连和感染。
在三年期间共确定了 105 例患者,其中 52 例符合纳入标准。1 期组 28 例,2 期组 24 例。平均随访 21.8 个月,87%的患者随访时间至少 12 个月。1 期组确定性固定的平均天数为 1.2 天,2 期组为 7.8 天。两组在伤口愈合或任何其他手术相关并发症方面无差异。两组的功能结局 PROMIS 相似。2 期组的平均植入物成本比 1 期组高 10821 美元,主要是由于外固定的成本。2 期组的住院总费用中位数比 1 期组高出 68000 多美元,所有 BTP 骨折和单纯 BTP 骨折分别高出 61000 多美元。
在适当选择的患者中,BTP 骨折的早期单阶段治疗具有成本效益,且与 2 阶段治疗相比,并发症发生率没有增加。
治疗性 3 级。欲了解完整的证据水平说明,请参阅作者指南。